| scholarly article | Q13442814 |
| P2093 | author name string | Christian L Roth | |
| P2860 | cites work | Hypothalamic mTOR signaling regulates food intake | Q28239714 |
| Weight gain in craniopharyngioma--a model for hypothalamic obesity | Q28303668 | ||
| Central nervous system control of food intake | Q29547439 | ||
| Central nervous system control of food intake and body weight | Q29619020 | ||
| A novel rodent model that mimics the metabolic sequelae of obese craniopharyngioma patients | Q30418917 | ||
| Forebrain melanocortin signaling enhances the hindbrain satiety response to CCK-8. | Q33395940 | ||
| Gut hormone PYY(3-36) physiologically inhibits food intake | Q34143493 | ||
| Measurement of oxygen consumption and locomotor activity in monosodium glutamate-induced obesity | Q34261114 | ||
| Appetite control | Q34389904 | ||
| Insulin, food intake, and reward | Q35120252 | ||
| Novel therapeutic targets for appetite regulation. | Q36129996 | ||
| Drugs on the horizon for diabesity. | Q36269675 | ||
| Central nervous system regulation of food intake | Q36461880 | ||
| The endocrine outcome after surgical removal of craniopharyngiomas | Q72496264 | ||
| Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity | Q79260157 | ||
| Reduced sympathetic metabolites in urine of obese patients with craniopharyngioma | Q80362433 | ||
| More or less? Treatment strategies in childhood craniopharyngioma | Q81557108 | ||
| Craniopharyngioma classification | Q82736502 | ||
| Craniopharyngioma and hypothalamic obesity in children | Q82844879 | ||
| Modulation of food reward by adiposity signals | Q36669744 | ||
| Role of dorsomedial hypothalamic neuropeptide Y in energy homeostasis | Q36695493 | ||
| Experimental Hypothalamic Hyperphagia in the Albino Rat. | Q37012284 | ||
| The brain, appetite, and obesity | Q37043569 | ||
| Childhood craniopharyngioma. Recent advances in diagnosis, treatment and follow-up. | Q37060191 | ||
| Insulin, leptin, and food reward: update 2008. | Q37086372 | ||
| Outcomes following endoscopic, expanded endonasal resection of suprasellar craniopharyngiomas: a case series | Q37203307 | ||
| Appetite disturbance and the problems of overweight | Q37942268 | ||
| Changes of peripheral alpha-melanocyte-stimulating hormone in childhood obesity | Q38350359 | ||
| Functional neuroimaging in craniopharyngioma: a useful tool to better understand hypothalamic obesity? | Q39610393 | ||
| Neuroregulators and feeding: implications for the pharmacological manipulation of hunger and appetite | Q40091585 | ||
| Risk factors for the development of obesity in children surviving brain tumors | Q40606322 | ||
| Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted? | Q41017827 | ||
| Evidence that NPY-containing neurons in the brainstem project into selected hypothalamic nuclei: implication in feeding behavior | Q41412250 | ||
| Rats with hypothalamic obesity are insensitive to central leptin injections | Q41692358 | ||
| Glucocorticoid-dependency of increased adiposity in a model of hypothalamic obesity. | Q42462134 | ||
| Appetite-regulating hormone changes in patients with craniopharyngioma | Q43522390 | ||
| MSG lesions decrease body mass of suckling-age rats by attenuating circadian decreases of energy expenditure | Q44095736 | ||
| Parasympathetic activity changes insulin response to glucose and neurotransmitters | Q44399117 | ||
| Slowing of intestinal transit by fat or peptide YY depends on β-adrenergic pathway | Q44653211 | ||
| Insulin secretion in monosodium glutamate (MSG) obese rats submitted to aerobic exercise training. | Q44893321 | ||
| Endocrine and neuroanatomic features associated with weight gain and obesity in adult patients with hypothalamic damage | Q45216248 | ||
| Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes | Q46458868 | ||
| The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway | Q46464837 | ||
| Food deprivation-induced changes in body fat mobilization after neonatal monosodium glutamate treatment | Q46840769 | ||
| Children with craniopharyngioma. Early growth failure and rapid postoperative weight gain | Q47179290 | ||
| Ventromedial hypothalamus modulates fat mobilisation during fasting | Q48166695 | ||
| Melanocortinergic activation by melanotan II inhibits feeding and increases uncoupling protein 1 messenger ribonucleic acid in the developing rat. | Q48215174 | ||
| Effects of monosodium L-glutamate administration on neuropeptide Y-containing neurons in the rat hypothalamus | Q48365107 | ||
| Improved yield of obese rats using a double coordinate system to locate the ventromedial or paraventricular nucleus | Q48373453 | ||
| Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus | Q48436589 | ||
| Amygdalo-hypothalamic circuit allows learned cues to override satiety and promote eating. | Q48479594 | ||
| An arcuato-paraventricular and -dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat. | Q48505077 | ||
| Rats lighten up with MCH antagonist | Q48525057 | ||
| PVN-lesioned obese rats maintain ambulatory activity and its circadian rhythm | Q48773312 | ||
| Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. | Q50746194 | ||
| The physiology of motivation. | Q51344778 | ||
| Studies of different female rat models of hypothalamic obesity. | Q51453883 | ||
| Gastric bypass surgery for treatment of hypothalamic obesity after craniopharyngioma therapy. | Q51467265 | ||
| Studies of gene expression in liver of insulin-like growth factor (IGF)-I, IGF binding protein-3 and growth hormone (GH) receptor/GH binding protein in rats treated neonatally with monosodium glutamate. | Q52213489 | ||
| First experiences with laparoscopic adjustable gastric banding (LAGB) in the treatment of patients with childhood craniopharyngioma and morbid obesity. | Q52292248 | ||
| Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. | Q53531526 | ||
| A pharmacological analysis of food intake regulation in rats treated neonatally with monosodium L-glutamate (MSG). | Q53881901 | ||
| Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite. | Q55067371 | ||
| Obesity after childhood craniopharyngioma - German multicenter study on pre-operative risk factors and quality of life | Q56900366 | ||
| [Craniopharyngioma in children. Endocrine evaluation and treatment. Apropos of 37 cases] | Q68694996 | ||
| Endocrine aspects of tumors arising from suprasellar, third ventricular regions | Q69247121 | ||
| Intellectual and psychosocial functions of children, adolescents and young adults before and after operation for craniopharyngioma | Q71063679 | ||
| P921 | main subject | obesity | Q12174 |
| craniopharyngioma | Q1786513 | ||
| P304 | page(s) | 49 | |
| P577 | publication date | 2011-10-14 | |
| P1433 | published in | Frontiers in Endocrinology | Q27723680 |
| P1476 | title | Hypothalamic obesity in patients with craniopharyngioma: profound changes of several weight regulatory circuits | |
| P478 | volume | 2 |
| Q42720561 | A rare presentation of craniopharyngioma: delayed puberty |
| Q37158294 | Activation of nuclear factor kappa B pathway and reduction of hypothalamic oxytocin following hypothalamic lesions |
| Q40704647 | Comparison of energy expenditure, body composition, metabolic disorders, and energy intake between obese children with a history of craniopharyngioma and children with multifactorial obesity |
| Q42224546 | Craniopharyngioma - a childhood and adult disease with challenging characteristics |
| Q34650930 | Effects of CB1 receptor blockade on monosodium glutamate induced hypometabolic and hypothalamic obesity in rats |
| Q34158925 | Hyperphagia: current concepts and future directions proceedings of the 2nd international conference on hyperphagia |
| Q26786921 | Hypothalamic Obesity in Craniopharyngioma Patients: Disturbed Energy Homeostasis Related to Extent of Hypothalamic Damage and Its Implication for Obesity Intervention |
| Q26799613 | Neuroendocrine Disorders in Pediatric Craniopharyngioma Patients |
| Q38948869 | Risk-adapted, long-term management in childhood-onset craniopharyngioma |
| Q48275188 | Specific behaviour, mood and personality traits may contribute to obesity in patients with craniopharyngioma |
Search more.